Investors in Corcept Therapeutics Incorporated (NASDAQ: CORT) saw the price of their shares crater 50% on December 31, 2025 after the company announced its receipt of a complete response letter ("CRL" ...

Early-stage regulatory strategy is becoming a powerful driver of speed, risk reduction, and commercial value in drug ...

In early December, the 2025 updates of China’s National Reimbursement Drug List (NRDL) were finalised with a total of 114 drugs, including Western drugs and traditional Chinese medicines, being newly ...

As drug candidates discovered via AI move into later-stage clinical trials, the technology seems to be doing as promised: ...

There is a good reason for health insurers to occasionally require prior authorization for medical treatment. If a doctor ...

Discover how early CMC, process optimization, and formulation strategy drive scalable, commercially viable drugs.

Indian drugmakers, known for their chemistry and prowess in making generics—cheaper copies of innovative drugs—for the world, have started pivoting towards innovation to stay competitive globally.

Natchez man charged with arson and multiple drug felonies after semi-truck fire; held without bond, Adams County sheriff says ...

For customs agents at Paris’s Charles de Gaulle airport, the haul was like nothing they had ever seen. Packed into 30 ...

LITTLE ROCK, AR - Trucking companies that place unqualified or dangerous drivers behind the wheel of commercial ...

Objective To help to clarify whether long term use of proton pump inhibitors is associated with an increased risk of gastric ...